Streetbeat News

Products Services

CYBN

Cybin Inc. has initiated dosing in the final cohort of its Phase 2 study evaluating CYB003, a potential treatment for major depressive disorder. The first five cohorts have completed dosing with no serious adverse events. The company expects to report Phase 2 efficacy topline data later this year and prepare for data submission to the FDA for pivotal studies. Completion of CYB003 dosing in MDD cohorts is expected in Q3 2023, with topline efficacy data readout expected in Q3/Q4 2023.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 11:02 am

ELVA

Electrovaya Inc. (NASDAQ:ELVA) has provided an update on its planned gigafactory in Jamestown, New York. The first phase of construction is expected to cost around $48 million, with over 80% of this covered by government-backed debt. The company has also been awarded more than $10 million in incentives from various jurisdictions. The factory will produce Electrovaya's Infinity line of lithium-ion ceramic batteries. The company plans to begin battery system assembly at the factory in Q1 2024.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 11:02 am

CELH

HUGE

KO

FSD Pharma Inc. (NASDAQ:HUGE) has signed an agreement with Celly Nutrition Inc. to launch UNBUZZD, a rapid alcohol detoxification drink. The launch will be led by former executives from Coca-Cola (NYSE:KO) and Celsius Holdings (NASDAQ:CELH). FSD Pharma will receive a 7% royalty on revenue from Celly Nutrition until a total of $250 million has been paid, after which the rate will be reduced to 3%. FSD Pharma has also been issued 100 million common shares in Celly Nutrition and an anti-dilution warrant.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 11:01 am

TOVX

Theriva Biologics has initiated patient dosing in the U.S. for its VIRAGE Phase 2B trial of VCN-01 in combination with chemotherapy as a first-line therapy for metastatic pancreatic ductal adenocarcinoma. The company expects to complete enrollment by Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 10:59 am

TOVX

Theriva Biologics (NYSE:TOVX) announced progress in VIRAGE, a Phase 2b clinical trial evaluating VCN-01 in combination with chemotherapy for metastatic pancreatic ductal adenocarcinoma. Patient dosing has begun in the U.S. and Spain, with the trial expected to be fully-enrolled by Q1 2024. The treatment has been well tolerated with a consistent safety profile.

Portfolio Pulse from Charles Gross

August 04, 2023 | 10:58 am

PLL

Piedmont Lithium (NASDAQ:PLL) announced the first commercial shipment of spodumene concentrate produced by North American Lithium, a joint venture between Piedmont (25%) and Sayona Mining (75%). The initial shipment was 20,500 metric tons.

Portfolio Pulse from Charles Gross

August 04, 2023 | 10:54 am

EWG

VOD

Vodafone Germany and 1&1 Mobilfunk GmbH have agreed on a long-term national roaming partnership. This will provide 5G mobile coverage nationwide to 1&1's customers from the second half of 2022.

Portfolio Pulse from Charles Gross

August 04, 2023 | 10:53 am

GME

IRDM

PSX

SBUX

TSLA

Key market headlines include Starbucks, Phillips 66, and Cathie Wood's investment in a payments software firm and Iridium stock. Crypto news highlights Binance's success in China and Microstrategy's plans to acquire more Bitcoin. In politics, Trump's NFT sales have surged following his indictment. Tech news includes Instagram's new feature to label AI-made posts. In the EV sector, Tesla faces regulatory scrutiny and potential harm from price cuts. Consumer news includes Toyota's US return, Uber's chatbot plan, and GameStop dropping crypto wallet support.

Portfolio Pulse from Akanksha Bakshi

August 04, 2023 | 10:52 am

AMGN

IDYA

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) and Amgen (NASDAQ:AMGN) have announced the start of a Phase 1/2 clinical trial evaluating the combination of IDE397 and AMG 193 in patients with MTAP deletion tumors. The trial is sponsored by Amgen and focuses on NSCLC.

Portfolio Pulse from Charles Gross

August 04, 2023 | 10:47 am

COIN

SQ

Block Inc CEO Jack Dorsey has expressed interest in partnering with Coinbase to prioritize the development and adoption of Bitcoin's lightning network. Dorsey has previously criticized Coinbase CEO Brian Armstrong for perceived lack of attention towards Bitcoin and lightning technology. Armstrong responded by assuring Dorsey of Coinbase's commitment to Bitcoin's growth and expressed interest in adding Lightning to their platform.

Portfolio Pulse from Mehab Qureshi

August 04, 2023 | 10:44 am